Mesothelioma Treatment
Mesothelioma Cancer
- Causes of Mesothelioma
- Mesothelioma Symptoms
- Mesothelioma Diagnosis
- Mesothelioma Stages
- Mesothelioma Treatment
- Innovative Mesothelioma Treatments
- Managing Mesothelioma Pain
- Nutrition Information for Mesothelioma Patients
- Specialized Mesothelioma Care
- Mesothelioma Risks
- Mesothelioma Support Groups
- Find a Mesothelioma Attorney
- Mesothelioma News
Mesothelioma Directory
Pharmacokinetic, Safety, and Efficacy Effects of Oral LBH589 on Dextromethorphan in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer or Malignant Pleural Mesothelioma
Get Help Today
Looking for help or additional information? Contact us today.| Conditions: | Carcinoma, Non-Small-Cell Lung|Mesothelioma |
| Start Date: | November 1, 2007 |
| Phase: | Phase I |
| Status: | Completed |
| NCT ID: | NCT00535951 |
| Study Type: | Interventional |
| Intervention: | Drug: LBH589 |
| Study Design: | Allocation: Non-Randomized|Control: Active Control|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | Novartis Pharmaceuticals |
| Ages: | Adult|Senior |
| Enrollment: | 18 |
| Funded By: | Industry |
| First Received: | September 26, 2007 |
| End Date: | |
| Last Updated: | January 14, 2010 |
| Last Verified: | January 1, 2010 |